For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Collaboration revenue | 0 | |||
| Research and development | 19,522,000 | |||
| General and administrative | 16,991,000 | |||
| Total operating expenses | 36,513,000 | |||
| Loss from operations | -36,513,000 | |||
| Interest expense | 90,000 | |||
| Change in fair value of warrant liability | 3,500,000 | |||
| Interest and other income, net | 1,137,000 | |||
| Net loss and comprehensive loss | -38,966,000 | |||
| Basic EPS | -50.83 | |||
| Diluted EPS | -50.83 | |||
| Basic Average Shares | 766,598 | |||
| Diluted Average Shares | 766,598 | |||
SPRUCE BIOSCIENCES, INC. (SPRB)
SPRUCE BIOSCIENCES, INC. (SPRB)